1-(4-methyl-1(2)H-pyrazol-3-yl)-ethanone | 68809-57-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-(4-methyl-1(2)H-pyrazol-3-yl)-ethanone
• 英文别名: 1-(4-Methyl-1(2)H-pyrazol-3-yl)-aethanon；Acetyl-3-methyl-4-pyrazol；3-Acetyl-4-methyl-1H-pyrazole；1-(4-methyl-1H-pyrazol-5-yl)ethanone
• CAS: 68809-57-4
• 化学式: C₆H₈N₂O
• 分子量: 124.142
• InChiKey: FGZYMXDKFSYYMU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  45.8
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-methyl-1(2)H-pyrazol-3-yl)-ethanone 在 sodium hydroxide 、 sulfur 作用下， 生成 (4-methyl-1(2)H-pyrazol-3-yl)-acetic acid
  参考文献：
  名称：

  451.一些吡唑基乳酸的制备和性质

  摘要：

  DOI：

  10.1039/jr9570002356
• 作为产物：
  描述：

  5-acetyl-4-methyl-1H-pyrazole-3-carboxylic acid 生成 1-(4-methyl-1(2)H-pyrazol-3-yl)-ethanone
  参考文献：
  名称：

  Klages; Roenneburg, Chemische Berichte, 1903, vol. 36, p. 1131

  摘要：

  DOI：

文献信息

• Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of MGLUR2 receptors
  申请人：Janssen Pharmaceutica NV

  公开号：US10005786B2

  公开（公告）日：2018-06-26

  The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives of Formula (I) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 (“mGluR2”). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved.

  本发明涉及式 (I) 的新型 6,7-二氢吡唑并[1,5-a]吡嗪-4(5H)-酮衍生物 作为代谢型谷氨酸受体亚型 2（"mGluR2"）的负异位调节剂（NAMs）。本发明还涉及包含此类化合物的药物组合物、制备此类化合物和组合物的工艺，以及使用此类化合物和组合物预防或治疗涉及代谢型受体 mGluR2 亚型的疾病。
• Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptors
  申请人：Janssen Pharmaceutica NV

  公开号：US10005785B2

  公开（公告）日：2018-06-26

  The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives of Formula (I) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 (“mGluR2”). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved.

  本发明涉及式 (I) 的新型 6,7-二氢吡唑并[1,5-a]吡嗪-4(5H)-酮衍生物 作为代谢型谷氨酸受体亚型 2（"mGluR2"）的负异位调节剂（NAMs）。本发明还涉及包含此类化合物的药物组合物、制备此类化合物和组合物的工艺，以及使用此类化合物和组合物预防或治疗涉及代谢型受体 mGluR2 亚型的疾病。
• 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
  申请人：Janssen Pharmaceutica NV

  公开号：US20170217971A1

  公开（公告）日：2017-08-03

  The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 (“mGluR2”). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved.
• US8513252B2
  申请人：——

  公开号：US8513252B2

  公开（公告）日：2013-08-20
• US9073907B2
  申请人：——

  公开号：US9073907B2

  公开（公告）日：2015-07-07